Hester acquires technology for production, commercialization of classical swine fever vaccine, sheep pox vaccine

08 Apr 2021

Hester Biosciences has signed two agreements with ICAR-IVRI (Indian Council of Agricultural Research - Indian Veterinary Research Institute), for acquiring technologies for the production and commercialisation of the vaccines -- ‘Classical Swine Fever Vaccine’ and ‘Sheep Pox Vaccine’.

These vaccines are the first that have been developed within the country by using locally isolated strains, a step towards making India self-sufficient, Atmanirbhar, for the country’s requirement of Classical Swine Fever Vaccine and Sheep Pox Vaccine.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Related Hester Biosciences Ltd. Links:

Hester Biosciences Share Price

2349.45 336.45 (16.71%) Apr 16, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 646.05
Dr. Reddys Lab 4893.00
Lupin 1055.85
Piramal Enterprises 1719.50
Cadila Healthcare 527.00
View more..
Sensex vs Hester Biosciences
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback